This contract expires in 18 days (Jun 30, 2026).
UNIVERSITY OF ROCHESTER - THE PRIMARY OBJECTIVES OF THIS RESEARCH PROJECT IS TO ANALYZE THE CONSTITUENTS DERIVED FROM SYNTHETIC COOLANT IN HEATED AEROSOLS AND TO PERFORM CYTOTOXICITY AND GENOTOXICITY SCREENING ON PULMONARY CELLS TREATED WITH SYNTHETIC COOLANT AEROSOLS
Key Details
Description
THE PRIMARY OBJECTIVES OF THIS RESEARCH PROJECT IS TO ANALYZE THE CONSTITUENTS DERIVED FROM SYNTHETIC COOLANT IN HEATED AEROSOLS AND TO PERFORM CYTOTOXICITY AND GENOTOXICITY SCREENING ON PULMONARY CELLS TREATED WITH SYNTHETIC COOLANT AEROSOLS
Context & Analysis
On Jan 21, 2026, Department of Health and Human Services obligated $846,191 to UNIVERSITY OF ROCHESTER for the primary objectives of this research project is to analyze the constituents derived from synthetic coolant in heated aerosols and to perform cytotoxicity and genotoxicity screening on pulmonary cel…. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: competed under sap with 2 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in ROCHESTER, NY. The contract is scheduled through Jun 30, 2026 — approximately 1 month remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.
Contractor Information
Similar Awards
NCI OPERATIONAL TASK ORDER, FY26-FY27
LEIDOS BIOMEDICAL RESEARCH INC
$327.1M
MD NET
LEIDOS BIOMEDICAL RESEARCH INC
$163.5M
ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
LEIDOS BIOMEDICAL RESEARCH INC
$141.7M
AWARD OF THE BASE TO ST. JUDE FOR CEIRR CONTRACT 75N93021C00016. THIS CONTRACT WILL SUPPORT NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR).
ST JUDE CHILDREN'S RESEARCH HOSPITAL INC
$103.3M
DOMESTIC INDUSTRIAL BASE EXPANSION OF KEY CHEMICALS FOR ACRYLONITRILE BUTADIENE RUBBER (NBR)
ASCEND PERFORMANCE MATERIALS TEXAS INC
$87.7M
Stay Updated
Get notified about new opportunities matching your interests.